Physician profile
Douglas Constant
NPI 1891917779
$3,464.04
in general payments reported to CMS, 2019-2025
32 companies · $718 in 2025
The $718 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $841 · 2020: $148 · 2021: $199 · 2022: $369 · 2023: $519 · 2024: $670 · 2025: $718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,715 · Education: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,715.43 |
| Education | $191.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $591.38 | 2019-2025 | Intracept |
| Nevro Corp. | $552.16 | 2019-2024 | Senza |
| Abbvie INC. | $283.00 | 2021-2025 | Botox, Qulipta |
| Vertiflex, INC. | $222.93 | 2019 | |
| Curonix LLC | $191.82 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $184.17 | 2024-2025 | Sprint Pns System |
| Stryker Corporation | $163.68 | 2025 | Mild Device Kit |
| Allergan, INC. | $157.27 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $145.54 | 2019 | |
| Pfizer INC. | $93.37 | 2019-2023 | |
| Globus Medical, INC. | $92.48 | 2025 | Senza |
| Amgen INC. | $91.06 | 2019-2020 | |
| Abbott Laboratories | $81.66 | 2019-2024 | Proclaim |
| Teva Pharmaceuticals USA, INC. | $77.64 | 2019-2020 | |
| Vertos Medical, INC. | $56.69 | 2022-2024 | Mild Device Kit |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $49.50 | 2023-2024 | Painteq |
| Lilly USA, LLC | $41.67 | 2019-2020 | |
| Nalu Medical, INC. | $39.99 | 2021-2025 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $39.38 | 2025 | |
| Scilex Pharmaceuticals INC. | $33.11 | 2019-2022 | |
| Medtronic, INC. | $31.98 | 2025 | Inceptiv |
| Horizon Therapeutics Plc | $31.36 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $28.70 | 2022 | |
| Coastal Medical Technologies LLC | $26.95 | 2025 | |
| Stimwave Technologies Incorporated | $26.14 | 2021-2022 | |
| Si-Bone, INC. | $22.62 | 2025 | |
| Impel Pharmaceuticals INC. | $21.54 | 2022 | |
| Relievant Medsystems, INC. | $20.87 | 2022 | |
| Vertical Pharmaceuticals, LLC | $18.78 | 2019 | |
| Ibsa Pharma INC. | $18.75 | 2021 | |
| Convatec INC. | $15.63 | 2023 | |
| Medtronic USA, INC. | $12.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Constant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.